-
91.
公开(公告)号:US11464820B2
公开(公告)日:2022-10-11
申请号:US16783962
申请日:2020-02-06
申请人: Brandeis University
发明人: Kenneth C. Hayes , Daniel Perlman
摘要: Methods of improving mammalian carbohydrate metabolism and treating, preventing, or halting the progression of type 2 diabetes mellitus involve the consumption of a nutritional composition containing fruit or vegetable pomace. The pomace is produced from native plant tissue and contains a mixture of soluble and insoluble fiber. Periodic consumption of the composition normalizes blood glucose concentration and controls body weight.
-
公开(公告)号:US11358863B2
公开(公告)日:2022-06-14
申请号:US16776789
申请日:2020-01-30
申请人: BRANDEIS UNIVERSITY
IPC分类号: C01B11/02 , A01N59/00 , A01N35/02 , A01N25/10 , A01N25/04 , A61L15/60 , A61L2/20 , A61L15/24 , A61L15/28 , A61L15/18 , A61L15/20 , A61L2/00 , A61L15/46
摘要: A composition and method for chlorine dioxide production through reaction-diffusion chemistry that facilitates the in situ generation of chlorine dioxide, wherein a dry solid composition of hydroxymethanesulfinic acid monosodium salt dihydrate (abbreviated HMS) and a chlorine dioxide precursor are activated via the addition or absorption of water to produce chlorine dioxide. The dry solid chemical composition comprises dry, safe, transportable reagents that integrate with polymeric materials such as packaging and superabsorbent and stimuli-responsive hydrogel polymers to combine with water to produce chlorine dioxide.
-
公开(公告)号:US11332504B2
公开(公告)日:2022-05-17
申请号:US16739561
申请日:2020-01-10
申请人: Brandeis University
发明人: Greg Petsko , Dagmar Ringe , Shulin Ju
IPC分类号: A61K38/00 , A61K49/00 , C07K14/00 , C07K14/48 , C12N15/00 , C12N15/09 , C12N15/12 , C12N15/13 , C12N15/11 , C07K14/47 , A61K38/17 , G01N33/50 , A61K9/00 , C12Q1/02 , A61K31/7125 , A61K48/00 , A61K31/7088 , A61K31/711 , A61K31/7105 , A61K31/7115 , C12Q1/6883 , A61K35/12 , C12N15/85 , A61P3/00 , A01K67/027
摘要: Nonsense-mediated mRNA decay (NMD) polypeptides, nucleic acids encoding NMD polypeptides, and methods of using such polypeptides and nucleic acids in the treatment of ALS and in screening for agents for the treatment of ALS are described.
-
公开(公告)号:US20220112240A1
公开(公告)日:2022-04-14
申请号:US17537418
申请日:2021-11-29
申请人: BRANDEIS UNIVERSITY
发明人: Hongjian HE , Bing XU
摘要: The present invention relates to a branched peptide that includes a first peptide chain and a second peptide chain having its C-terminal amino acid covalently linked to a sidechain of an amino acid residue of the first peptide chain, wherein the first peptide chain includes a plurality of aromatic amino acids and, optionally, an aromatic group linked to an amino terminus of the first peptide chain; and the second peptide chain includes a plurality of hydrophilic amino acids and an enzyme cleavage site. Pharmaceutical compositions containing the branched peptide and one or more therapeutic agents in an aqueous medium are disclosed, where the branched peptides form micelle structures in the aqueous medium. Methods of using the pharmaceutical composition to deliver therapeutic agents, and for treating various disease conditions are also described.
-
公开(公告)号:USD947030S1
公开(公告)日:2022-03-29
申请号:US29649503
申请日:2018-05-30
申请人: Brandeis University
设计人: Daniel Perlman
-
公开(公告)号:US11268099B2
公开(公告)日:2022-03-08
申请号:US16538291
申请日:2019-08-12
申请人: Brandeis University
发明人: Isaac J. Krauss
IPC分类号: C12N15/117 , C12Q1/6886 , G01N33/574 , C07H21/04 , A61K39/21 , C12N15/10 , C12P19/34 , G01N33/53 , G01N33/68 , A61K39/00
摘要: The invention relates to an oligonucleotide including one or more modified nucleoside bases having the structure -B-L-A wherein for each of the modified nucleosides A is independently a monosaccharide or oligosaccharide, Lisa linker molecule, and B is independently a pyrimidine or pyridine base linked to the sugar-phosphate backbone of the oligonucleotide; and wherein the oligonucleotide binds specifically to a carbohydrate-binding monoclonal antibody with an affinity of less than 100 nM. Immunogenic conjugates that include the oligonucleotide, and pharmaceutical compositions that include the oligonucleotide or the immunogenic conjugate are also disclosed. Various method of using the oligonucleotides, immunogenic conjugates, and pharmaceutical compositions are disclosed, including inducing an immune response, inhibiting viral or bacterial infection, treating a cancerous condition, and detecting a neutralizing antibody. A method is also disclosed for selecting the oligonucleotides using an alternative Selection of Modified Aptamers (SELMA).
-
公开(公告)号:US11266616B2
公开(公告)日:2022-03-08
申请号:US16075550
申请日:2017-02-08
申请人: BRANDEIS UNIVERSITY
发明人: Dorothee Kern , Adelajda Zorba
IPC分类号: C07K16/00 , A61K39/395 , A61K31/192 , A61K45/06 , A61K31/496 , A61K31/517 , C07K16/40 , C12Q1/48 , G16B15/30 , A61P35/00 , G16B15/00 , A61K9/00 , G16C20/50
摘要: The present invention features therapeutic compositions comprising an agent that specifically binds to a PIF pocket of Aurora A kinase and an agent that specifically binds to an ATP-binding site of Aurora A kinase, and the use of the therapeutic compositions to modulate Aurora A kinase for the treatment of cancer.
-
公开(公告)号:US11191724B2
公开(公告)日:2021-12-07
申请号:US16648295
申请日:2018-09-18
申请人: BRANDEIS UNIVERSITY
发明人: Hongjian He , Bing Xu
摘要: The present invention relates to a branched peptide that includes a first peptide chain and a second peptide chain having its C-terminal amino acid covalently linked to a sidechain of an amino acid residue of the first peptide chain, wherein the first peptide chain includes a plurality of aromatic amino acids and, optionally, an aromatic group linked to an amino terminus of the first peptide chain; and the second peptide chain includes a plurality of hydrophilic amino acids and an enzyme cleavage site. Pharmaceutical compositions containing the branched peptide and one or more therapeutic agents in an aqueous medium are disclosed, where the branched peptides form micelle structures in the aqueous medium. Methods of using the pharmaceutical composition to deliver therapeutic agents, and for treating various disease conditions are also described.
-
公开(公告)号:US11148140B2
公开(公告)日:2021-10-19
申请号:US16477749
申请日:2018-01-16
申请人: BRANDEIS UNIVERSITY
发明人: Seth Fraden
摘要: A microfluidic device comprising at least one isolation unit and at least one capillary valve. The at least one isolation unit has at least one chamber. The at least one chamber configured to receive at least two different aqueous solutions. The at least one capillary valve is configured to allow for the at least two different aqueous solutions to be introduced into the at least one chamber without mixing prior to entering the at least one chamber based at least in part on pressure levels of the at least two different aqueous solutions.
-
公开(公告)号:US20210178395A1
公开(公告)日:2021-06-17
申请号:US17184202
申请日:2021-02-24
发明人: Seth Fraden , Hakim Boukellal , Yanwei Jia , Seila Selimovic , Amy Rowat , Jeremy Agresti , David A. Weitz
摘要: Microfluidic structures and methods for manipulating fluids, fluid components, and reactions are provided. In one aspect, such structures and methods can allow production of droplets of a precise volume, which can be stored/maintained at precise regions of the device. In another aspect, microfluidic structures and methods described herein are designed for containing and positioning components in an arrangement such that the components can be manipulated and then tracked even after manipulation. For example, cells may be constrained in an arrangement in microfluidic structures described herein to facilitate tracking during their growth and/or after they multiply.
-
-
-
-
-
-
-
-
-